SC 13G/A 1 tm216523d6_sc13ga.htm SC 13G/A

 

  

  UNITED STATES  
  SECURITIES AND EXCHANGE COMMISSION  
  Washington, D.C. 20549  

 

SCHEDULE 13G/A

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

Relmada Therapeutics, Inc.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

75955J402

(CUSIP Number)

 

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
Venrock Healthcare Capital Partners II, L.P.
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)
 

  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
PN

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 2 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
VHCP Co-Investment Holdings II, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 3 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
Venrock Healthcare Capital Partners III, L.P.
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
PN

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 4 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
VHCP Co-Investment Holdings III, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 5 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
VHCP Management II, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 6 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
VHCP Management III, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 7 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
Shah, Nimish
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
United States

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
IN

 

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 8 

 

 

CUSIP No. 75955J402
 
  1. Name of Reporting Persons
Koh, Bong
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) ¨
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
United States

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:		 5. Sole Voting Power
0
 
6. Shared Voting Power
668,440(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
668,440(2)
 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
668,440(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
 
  11. Percent of Class Represented by Amount in Row (9)
4.1%(3)
 
  12. Type of Reporting Person (See Instructions)
IN
         

 

(1) Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
(2) Consists of 61,894 shares owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares owned by VHCP Co-Investment Holdings III, LLC.
(3) This percentage is calculated based upon 16,241,526 shares of the Issuer’s common stock outstanding as of November 9, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.

 

 9 

 

 

CUSIP No. 75955J402

 

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II LP”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III” and collectively with VHCP II LP, VHCP Co-Investment II, VHCP III LP, VHCP Co-Investment III and VHCP Management II, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of Common Stock of Relmada Therapeutics, Inc.

 

Item 1.
  (a) Name of Issuer
Relmada Therapeutics, Inc.
  (b)

Address of Issuer’s Principal Executive Offices

880 Third Avenue, 12th Floor

New York, NY 10022

 
Item 2.
  (a)

Name of Person Filing
Venrock Healthcare Capital Partners II, L.P.

VHCP Co-Investment Holdings II, LLC

Venrock Healthcare Capital Partners III, L.P.

VHCP Co-Investment Holdings III, LLC

VHCP Management II, LLC

VHCP Management III, LLC

Nimish Shah

Bong Koh

  (b) Address of Principal Business Office or, if none, Residence
    New York Office: Palo Alto Office:  
    7 Bryant Park 3340 Hillview Avenue  
    23rd Floor Palo Alto, CA 94304  
    New York, NY 10018    
  (c)

Citizenship

All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.

  (d)

Title of Class of Securities

Common Stock, par value $0.001 per share

  (e)

CUSIP Number

75955J402

 

 10 

 

 

CUSIP No. 75955J402

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable
   
Item 4. Ownership
  (a) Amount Beneficially Owned as of December 31, 2020:
      Venrock Healthcare Capital Partners II, L.P.   668,440 (1)  
      VHCP Co-Investment Holdings II, LLC   668,440 (1)  
      Venrock Healthcare Capital Partners III, L.P.   668,440 (1)  
      VHCP Co-Investment Holdings III, LLC   668,440 (1)  
      VHCP Management II, LLC   668,440 (1)  
      VHCP Management III, LLC   668,440 (1)  
      Nimish Shah   668,440 (1)  
      Bong Koh   668,440 (1)  
  (b) Percent of Class as of December 31, 2020:
      Venrock Healthcare Capital Partners II, L.P.   4.1 %  
      VHCP Co-Investment Holdings II, LLC   4.1 %  
      Venrock Healthcare Capital Partners III, L.P.   4.1 %  
      VHCP Co-Investment Holdings III, LLC   4.1 %  
      VHCP Management II, LLC   4.1 %  
      VHCP Management III, LLC   4.1 %  
      Nimish Shah   4.1 %  
      Bong Koh   4.1 %  
  (c) Number of shares as to which the person has, as of December 31, 2020:
    (i) Sole power to vote or to direct the vote
      Venrock Healthcare Capital Partners II, L.P.   0    
      VHCP Co-Investment Holdings II, LLC   0    
      Venrock Healthcare Capital Partners III, L.P.   0    
      VHCP Co-Investment Holdings III, LLC   0    
      VHCP Management II, LLC   0    
      VHCP Management III, LLC   0    
      Nimish Shah   0    
      Bong Koh   0    
                   

 11 

 

 

CUSIP No. 75955J402

 

    (ii) Shared power to vote or to direct the vote
      Venrock Healthcare Capital Partners II, L.P.   668,440 (1)  
      VHCP Co-Investment Holdings II, LLC   668,440 (1)  
      Venrock Healthcare Capital Partners III, L.P.   668,440 (1)  
      VHCP Co-Investment Holdings III, LLC   668,440 (1)  
      VHCP Management II, LLC   668,440 (1)  
      VHCP Management III, LLC   668,440 (1)  
      Nimish Shah   668,440 (1)  
      Bong Koh   668,440 (1)  
    (iii) Sole power to dispose or to direct the disposition of
      Venrock Healthcare Capital Partners II, L.P.   0    
      VHCP Co-Investment Holdings II, LLC   0    
      Venrock Healthcare Capital Partners III, L.P.   0    
      VHCP Co-Investment Holdings III, LLC   0    
      VHCP Management II, LLC   0    
      VHCP Management III, LLC   0    
      Nimish Shah   0    
      Bong Koh   0    
    (iv) Shared power to dispose or to direct the disposition of
      Venrock Healthcare Capital Partners II, L.P.   668,440 (1)  
      VHCP Co-Investment Holdings II, LLC   668,440 (1)  
      Venrock Healthcare Capital Partners III, L.P.   668,440 (1)  
      VHCP Co-Investment Holdings III, LLC   668,440 (1)  
      VHCP Management II, LLC   668,440 (1)  
      VHCP Management III, LLC   668,440 (1)  
      Nimish Shah   668,440 (1)  
      Bong Koh   668,440 (1)  
                   

 

(1) These shares are owned directly as follows: 61,894 shares are owned by Venrock Healthcare Capital Partners II, L.P., 25,087 shares are owned by VHCP Co-Investment Holdings II, LLC, 528,612 shares are owned by Venrock Healthcare Capital Partners III, L.P. and 52,847 shares are owned by VHCP Co-Investment Holdings III, LLC. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. Messrs. Shah and Koh are the voting members of VHCP Management II, LLC and VHCP Management III, LLC.

 

Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
 
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Not Applicable
 
Item 8. Identification and Classification of Members of the Group
Not Applicable
 
Item 9. Notice of Dissolution of a Group
Not Applicable
 

 

 12 

 

 

CUSIP No. 75955J402

 

Item 10. Certification

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 16, 2021

 

Venrock Healthcare Capital Partners II, L.P.   Venrock Healthcare Capital Partners III, L.P.
     
By: VHCP Management II, LLC   By: VHCP Management III, LLC
Its: General Partner   Its: General Partner
         
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  Name: David L. Stepp     Name: David L. Stepp
  Its: Authorized Signatory     Its: Authorized Signatory
     
VHCP Co-Investment Holdings II, LLC   VHCP Co-Investment Holdings III, LLC
     
By: VHCP Management II, LLC   By: VHCP Management III, LLC
Its: Manager   Its: Manager
         
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  Name: David L. Stepp     Name: David L. Stepp
  Its: Authorized Signatory     Its: Authorized Signatory
       
VHCP Management II, LLC   VHCP Management III, LLC
     
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  Name: David L. Stepp     Name: David L. Stepp
  Its: Authorized Signatory     Its: Authorized Signatory
     
Nimish Shah   Bong Koh
     
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  David L. Stepp, as attorney-in-fact     David L. Stepp, as attorney-in-fact

 

 13 

 

 

CUSIP No. 75955J402

 

EXHIBITS

 

A: Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on December 16, 2019)
B: Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed on December 16, 2019)
C: Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to Schedule 13G filed on December 16, 2019)

 

 14